JOINT FILING AGREEMENTJoint Filing Agreement • May 17th, 2022 • Richmond Brothers, Inc. • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of Ocuphire Pharma, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
